Here’s how much money Pfizer collected from COVID-19 vaccine shots in Q2

Invezz

Published

Pfizer Inc., (NYSE: PFE) announced that the company sold Covid-19 jabs worth $7.8 billion in the second quarter. In addition, the company raised its full-year 2021 sales estimates from the vaccine from $26 billion to $33.5 billion. The data was detailed in the company’s second quarter earnings results and comes during the backdrop of the […]

Full Article